A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers
Trial details
- Registry ID
- NCT05626803
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy VolunteersNCT05626803 | Vaxart | Phase 2 | Completed | 2023-10-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |